Abstract
1621P Efficacy and safety of erdafitinib in adults with pancreatic cancer and prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase II open-label: Single-arm RAGNAR trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have